Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1260

1.

Association between Advanced Fibrosis in Fatty Liver Disease and Overall Mortality based on Body Fat Distribution.

Chung GE, Heo NJ, Kim D, Kwak MS, Yim JY, Kim JS, Ahmed A.

J Gastroenterol Hepatol. 2019 Jul 4. doi: 10.1111/jgh.14778. [Epub ahead of print]

PMID:
31272131
2.

Pediatric IgA Nephropathy in Europe.

Coppo R.

Kidney Dis (Basel). 2019 Jun;5(3):182-188. doi: 10.1159/000495751. Epub 2019 Jan 24. Review.

PMID:
31259180
3.

Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease.

Kim Y, Chang Y, Cho YK, Ahn J, Shin H, Ryu S.

Liver Int. 2019 Jun 21. doi: 10.1111/liv.14184. [Epub ahead of print]

PMID:
31226232
4.

TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals.

Degasperi E, Galmozzi E, Facchetti F, Farina E, D'Ambrosio R, Soffredini R, Iavarone M, Lampertico P.

J Viral Hepat. 2019 Jun 8. doi: 10.1111/jvh.13155. [Epub ahead of print]

PMID:
31177595
5.

Investigation of congestive heart failure in beef cattle in a feedyard at a moderate altitude in western Nebraska.

Moxley RA, Smith DR, Grotelueschen DM, Edwards T, Steffen DJ.

J Vet Diagn Invest. 2019 Jul;31(4):509-522. doi: 10.1177/1040638719855108. Epub 2019 Jun 6.

PMID:
31170901
6.

Identification of clinical risk factors for histological progression of primary biliary cholangitis.

Fujinaga Y, Namisaki T, Moriya K, Kitade M, Kawaratani H, Shimozato N, Kaji K, Takaya H, Sawada Y, Seki K, Akahane T, Okura Y, Sato S, Saikawa S, Nakanishi K, Kubo T, Furukawa M, Kitagawa K, Ozutsumi T, Tsuji Y, Kaya D, Mashitani T, Ishida K, Ogawa H, Takagi H, Noguchi R, Mitoro A, Yamao J, Yoshiji H.

Hepatol Res. 2019 Apr 25. doi: 10.1111/hepr.13355. [Epub ahead of print]

PMID:
31021038
7.

Hepatitis C Virus Treatment with Directly Acting Agents Reduces the Risk of Incident Diabetes - Results from ERCHIVES.

Butt AA, Yan P, Aslam S, Shaikh OS, Abou-Samra AB.

Clin Infect Dis. 2019 Apr 12. pii: ciz304. doi: 10.1093/cid/ciz304. [Epub ahead of print]

PMID:
30977808
8.

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.

Wu W, Jordan S, Graf N, de Oliveira Pena J, Curram J, Allanore Y, Matucci-Cerinic M, Pope JE, Denton CP, Khanna D, Distler O; EUSTAR Collaborators.

Ann Rheum Dis. 2019 May;78(5):648-656. doi: 10.1136/annrheumdis-2018-213455. Epub 2019 Mar 9.

9.

Evaluation of bone disease in patients with cystic fibrosis and end-stage lung disease.

Robinson CA, Hofer M, Benden C, Schmid C.

J Bras Pneumol. 2019 Feb 28;45(1):e20170280. doi: 10.1590/1806-3713/e20170280. English, Portuguese.

10.

Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study.

Vilar-Gomez E, Athinarayanan SJ, Adams RN, Hallberg SJ, Bhanpuri NH, McKenzie AL, Campbell WW, McCarter JP, Phinney SD, Volek JS, Chalasani N.

BMJ Open. 2019 Feb 25;9(2):e023597. doi: 10.1136/bmjopen-2018-023597.

11.

WAITING DAAS LIST MORTALITY IMPACT IN HCV CIRRHOTIC PATIENTS.

Silva GF, Andrade VG, Moreira A.

Arq Gastroenterol. 2018 Oct-Dec;55(4):343-345. doi: 10.1590/S0004-2803.201800000-76.

12.

HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.

Ekong UD, Antala S, Bow L, Sese D, Morotti R, Rodriguez-Davalos M, Gan G, Deng Y, Emre SH.

Exp Clin Transplant. 2019 Jan;17(Suppl 1):6-17. doi: 10.6002/ect.MESOT2018.L30.

13.

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.

Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, De Ledinghen V, Larrey D, Haour G, Bronowicki JP, Zoulim F, Asselah T, Marcellin P, Thabut D, Leroy V, Tran A, Habersetzer F, Samuel D, Guyader D, Chazouilleres O, Mathurin P, Metivier S, Alric L, Riachi G, Gournay J, Abergel A, Cales P, Ganne N, Loustaud-Ratti V, D'Alteroche L, Causse X, Geist C, Minello A, Rosa I, Gelu-Simeon M, Portal I, Raffi F, Bourliere M, Pol S; French ANRS CO22 Hepather cohort.

Lancet. 2019 Apr 6;393(10179):1453-1464. doi: 10.1016/S0140-6736(18)32111-1. Epub 2019 Feb 11.

PMID:
30765123
14.

Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease.

Kim MC, Park JG, Jang BI, Lee HJ, Lee WK.

Medicine (Baltimore). 2019 Feb;98(6):e14139. doi: 10.1097/MD.0000000000014139.

15.

Technical Feasibility and Clinical Effectiveness of Transjugular Intrahepatic Portosystemic Shunt Creation in Pediatric and Adolescent Patients.

Bertino F, Hawkins CM, Shivaram G, Gill AE, Lungren MP, Reposar A, Sze DY, Hwang GL, Koo K, Monroe E.

J Vasc Interv Radiol. 2019 Feb;30(2):178-186.e5. doi: 10.1016/j.jvir.2018.10.003.

PMID:
30717948
16.

Exposure-Response Analysis for Efficacy of Daclatasvir, Asunaprevir, and Beclabuvir Combinations in HCV-Infected Patients.

Ueno T, Osawa M, Shiozaki T, Green M, Garimella T.

Clin Pharmacol Drug Dev. 2019 Jan 22. doi: 10.1002/cpdd.646. [Epub ahead of print]

PMID:
30667592
17.

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.

Javed Z, Papageorgiou M, Deshmukh H, Kilpatrick ES, Mann V, Corless L, Abouda G, Rigby AS, Atkin SL, Sathyapalan T.

Nutrients. 2019 Jan 17;11(1). pii: E188. doi: 10.3390/nu11010188.

18.

Variants in FAT1 and COL9A1 genes in male population with or without substance use to assess the risk factors for oral malignancy.

Chung CM, Hung CC, Lee CH, Lee CP, Lee KW, Chen MK, Yeh KT, Ko YC.

PLoS One. 2019 Jan 18;14(1):e0210901. doi: 10.1371/journal.pone.0210901. eCollection 2019.

19.

Evaluating Flexible Modeling of Continuous Covariates in Inverse-Weighted Estimators.

Kyle RP, Moodie EEM, Klein MB, Abrahamowicz M.

Am J Epidemiol. 2019 Jun 1;188(6):1181-1191. doi: 10.1093/aje/kwz004.

PMID:
30649165
20.

Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.

Azuma S, Asahina Y, Kakinuma S, Azuma K, Miyoshi M, Inoue E, Tsunoda T, Sato A, Kaneko S, Nagata H, Kawai-Kitahata F, Murakawa M, Nitta S, Itsui Y, Tomita M, Nakagawa M, Watanabe M.

Dig Dis. 2019;37(3):247-254. doi: 10.1159/000493580. Epub 2019 Jan 9.

PMID:
30625487

Supplemental Content

Loading ...
Support Center